Abstract:Prostate cancer (PCa) is one of the most prevalent diagnosed malignancies globally. Previous studies have demonstrated that prostaglandin E2 (PGE2) is closely associated with the tumorigenesis and progression of PCa. However, the underlying molecular mechanisms remain unclear and require further investigation. Matrix metalloproteinases (MMPs), receptor activator of nuclear factor‑κB ligand (RANKL) and runt‑related transcription factor 2 (RUNX2), which are involved in cell growth and bone metastasis, are frequently activated or overexpressed in various types of cancer, including PCa. The present study was designed to investigate the associations between PGE2 and the PGE2 receptor EP4, and MMPs, RANKL and RUNX2 in PCa, and to define their roles in PCa cell proliferation and invasion in addition to understanding the molecular mechanisms. The results of western blotting and reverse transcription‑quantitative polymerase chain reaction demonstrated that the protein and the mRNA expression levels of MMP‑2, MMP‑9, RANKL and RUNX2 in PC‑3 cells were significantly upregulated by treatment with PGE2, respectively, and knockdown of these proteins blocked PGE2‑induced cell proliferation and invasion in PC‑3 cells, as determined by Cell Counting Kit‑8 and Matrigel invasion assays, respectively. The effect of PGE2 on the protein and mRNA expression levels was primarily regulated via the EP4 receptor. EP4 receptor signaling activates the cyclic (c)AMP‑protein kinase A (PKA) signaling pathway, and forskolin, an activator of adenylate cyclase (AC), exhibited similar effects to an EP4 receptor agonist on the protein expression, while SQ22536, an inhibitor of AC, inhibited the protein expression. These results confirmed that the AC/cAMP pathway may be involved in EP4 receptor‑mediated upregulation of protein expression. By using a specific inhibitor of PKA, it was also demonstrated that cAMP/PKA was also involved in the EP4 receptor‑mediated upregulation of protein expression. In addition to the signaling pathway involving PKA, the EP4 receptor also exerts activities through activation of Akt kinase. The results in the present study confirmed the hypothesis that EP4 receptor‑mediated protein expression in PCa cells that were pretreated with a specific inhibitor of phosphatidylinositol 3‑kinase (PI3K) was significantly inhibited. In conclusion, the results of the present study indicate that PGE2 significantly upregulated the mRNA and protein expression levels of the MMP‑2, MMP‑9, RANKL and RUNX2, and the EP4 receptor was involved in the cell proliferation and invasion of PCa via the cAMP‑PKA/PI3K‑Akt signaling pathway. These results may provide novel insight into potential therapeutic strategies for the prevention and treatment of PCa.

PDE4 and Epac1 Synergistically Promote Rectal Carcinoma Via the Camp Pathway.

Epac1 is Involved in Cell Cycle Progression in Lung Cancer Through PKC and Cx43 Regulation

Epac1, PDE4, and PKC protein expression and their association with AKAP95, Cx43, and cyclinD2/E1 in breast cancer tissues.

Epac1, PDE4, and PKC protein expression and their correlation with AKAP95 and Cx43 in esophagus cancer tissues.

Synergistic Effects of AKAP95, Cyclin D1, Cyclin E1, and Cx43 in the Development of Rectal Cancer.

Upregulation of CPE promotes cell proliferation and tumorigenicity in colorectal cancer

Prostaglandin E2 Receptor EP4 is Involved in the Cell Growth and Invasion of Prostate Cancer Via the Camp‑pka/pi3k‑akt Signaling Pathway.

Correlation Between the Protein Expression Levels of A-kinase Anchor Protein95, P-Retinoblastoma (ser780), Cyclin D2/3, and Cyclin E2 in Esophageal Cancer Tissues

Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis

Epithelial cell adhesion molecule is an independent prognostic marker in clear cell renal carcinoma

Expression of P-EGFR and P-Akt Protein in Esophageal Squamous Cell Carcinoma and Its Prognosis

Expression of PSCA,OCT-4,CD24 and CD44 V6 in Rectal Cancer Tissues and Its Clinicopathological Significance

Cyclooxygenase-2 Expression is Dependent Upon Epidermal Growth Factor Receptor Expression or Activation in Androgen Independent Prostate Cancer

Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.

Coexpression of EGFR and CXCR4 Predicts Poor Prognosis in Resected Pancreatic Ductal Adenocarcinoma.

Prostaglandin E Receptor 4 (EP4) Promotes Colonic Tumorigenesis

PDCD10 Promotes the Aggressive Behaviors of Pituitary Adenomas by Up-Regulating CXCR2 and Activating Downstream AKT/ERK Signaling

Carboxypeptidase A4 Promotes Cell Growth Via Activating STAT3 and ERK Signaling Pathways and Predicts a Poor Prognosis in Colorectal Cancer.

EPCR Promotes MGC803 Human Gastric Cancer Cell Tumor Angiogenesis in Vitro Through Activating ERK1/2 and AKT in a PAR1-dependent Manner.

Expression of EGFR,Grb2,p-mTOR and VEGF in Human Colorectal Cancer Tissues

PDE4B promotes the progression of gastric cancer via the PI3K/AKT/MYC pathway and immune infiltration